Design and Synthesis of EZH2-Based PROTACs to Degrade the PRC2 Complex for Targeting the Noncatalytic Activity of EZH2Zhihao Liu, Luoting Yu, Xi Hu et al.|Journal of Medicinal Chemistry|2021Cited by 116
Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanomaYongxia Zhu, Yuquan Wei, Tinghong Ye et al.|Scientific Reports|2016Cited by 72
Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosisChao Gao, Yuquan Wei, Cuiting Peng et al.|Scientific Reports|2016Cited by 48
Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivativesCuiting Peng, Luoting Yu, Chao Gao et al.|Bioorganic & Medicinal Chemistry Letters|2015Cited by 45
Discovery of a Novel Covalent EZH2 Inhibitor Based on Tazemetostat Scaffold for the Treatment of Ovarian CancerQiangsheng Zhang, Luoting Yu, Guoquan Wan et al.|Journal of Medicinal Chemistry|2023Cited by 24